Caribou Biosciences, Inc. (CRBU)
NASDAQ: CRBU · IEX Real-Time Price · USD
3.700
-0.060 (-1.60%)
Apr 26, 2024, 11:36 AM EDT - Market open
Caribou Biosciences Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Caribou Biosciences stock have an average target of 22, with a low estimate of 19 and a high estimate of 24. The average target predicts an increase of 494.59% from the current stock price of 3.70.
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 19, 2024.
Analyst Ratings
The average analyst rating for CRBU stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 2 | 2 | 2 | 2 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $23 → $24 | Strong Buy | Maintains | $23 → $24 | +548.65% | Mar 19, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $19 | Buy | Reiterates | $19 | +413.51% | Mar 12, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Nov 8, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $25 → $23 | Strong Buy | Maintains | $25 → $23 | +521.62% | Jul 26, 2023 |
| Truist Securities | Truist Securities | Strong Buy Reiterates $23 | Strong Buy | Reiterates | $23 | +521.62% | Jul 14, 2023 |
Financial Forecast
Revenue This Year
12.52M
from 34.48M
Decreased by -63.69%
Revenue Next Year
13.23M
from 12.52M
Increased by 5.68%
EPS This Year
-1.78
from -1.38
EPS Next Year
-2.10
from -1.78
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 22.1M | 25.2M | 105.0M | 111.3M | 851.0M |
| Avg | 12.5M | 13.2M | 42.9M | 76.4M | 360.9M |
| Low | n/a | n/a | 9.8M | 16.3M | 136.0M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -36.0% | 101.3% | 693.8% | 159.4% | 1,013.9% |
| Avg | -63.7% | 5.7% | 224.3% | 78.1% | 372.3% |
| Low | - | - | -25.9% | -62.1% | 77.9% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.68 | -1.50 | -1.90 | -4.10 | -0.78 |
| Avg | -1.78 | -2.10 | -2.22 | -3.98 | -0.75 |
| Low | -1.99 | -2.91 | -2.71 | -3.82 | -0.73 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.